Caux; Christophe
Patent Applications and Registrations
Patent applications and USPTO patent grants for Caux; Christophe.The latest application filed is for "herv-k-derived antigens as shared tumor antigens for anti-cancer vaccine".
- Caux; Christophe - Lyons FR
- CAUX; Christophe - BRESSOLLES FR
- Caux; Christophe - Lyon Cedex FR
- Caux; Christophe - Lyon Cedex 08 FR
- Caux; Christophe - Lieu dit le Paillot FR
- Caux, Christophe - Lyon FR
| Patent | Date |
|---|---|
| Antibodies directed against ICOS and uses thereof Grant 11,180,556 - Faget , et al. November 23, 2 | 2021-11-23 |
| Herv-k-derived Antigens As Shared Tumor Antigens For Anti-cancer Vaccine App 20210330774 - DEPIL; Stephane ; et al. | 2021-10-28 |
| CD73 blocking agents Grant 11,130,817 - Caux , et al. September 28, 2 | 2021-09-28 |
| Antibodies Directed Against ICOS and Uses Thereof App 20200347134 - Faget; Julien ; et al. | 2020-11-05 |
| Antibodies directed against ICOS and uses thereof Grant 10,745,482 - Faget , et al. A | 2020-08-18 |
| Lymphocytes Expressing Cd73 In Cancerous Patient Dictates Therapy App 20200232974 - MENETRIER-CAUX; Christine ; et al. | 2020-07-23 |
| Antibodies directed against ICOS and uses thereof Grant 10,633,446 - Faget , et al. | 2020-04-28 |
| Antibodies Directed Against ICOS and Uses Thereof App 20190352400 - Faget; Julien ; et al. | 2019-11-21 |
| Antibodies Directed Against ICOS and Uses Thereof App 20190315866 - Faget; Julien ; et al. | 2019-10-17 |
| Cd73 Blocking Agents App 20190225703 - CAUX; CHRISTOPHE ; et al. | 2019-07-25 |
| Antibodies Directed Against ICOS and Uses Thereof App 20180244780 - Faget; Julien ; et al. | 2018-08-30 |
| Antibodies directed against ICOS and uses thereof Grant 9,975,950 - Faget , et al. May 22, 2 | 2018-05-22 |
| Antibodies Directed Against ICOS and Uses Thereof App 20170233478 - Faget; Julien ; et al. | 2017-08-17 |
| Antibodies directed against ICOS and uses thereof Grant 9,676,852 - Faget , et al. June 13, 2 | 2017-06-13 |
| Antibodies Directed Against ICOS and Uses Thereof App 20160264666 - Faget; Julien ; et al. | 2016-09-15 |
| Antibodies directed against ICOS and uses thereof Grant 9,376,493 - Faget , et al. June 28, 2 | 2016-06-28 |
| Antibodies Directed Against ICOS and Uses Thereof App 20140086923 - Faget; Julien ; et al. | 2014-03-27 |
| Use of the Combinatorial Diversity of T-Lymphocyte Repertoire as a Prognostic Marker of Cancer App 20120309013 - Caux; Christophe ; et al. | 2012-12-06 |
| Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors Grant 7,700,728 - Bates , et al. April 20, 2 | 2010-04-20 |
| Chemokines As Adjuvants Of Immune Response App 20100086560 - Caux; Christophe ; et al. | 2010-04-08 |
| Methods for Treating Cancer App 20090087440 - Vicari; Alain ; et al. | 2009-04-02 |
| Chemokines As Adjuvants Of Immune Response App 20070166280 - Caux; Christophe ; et al. | 2007-07-19 |
| Chemokines As Adjuvants Of Immune Response App 20070128159 - Vicari; Alain P. ; et al. | 2007-06-07 |
| Chemokines as adjuvants of immune response Grant 7,217,700 - Vicari , et al. May 15, 2 | 2007-05-15 |
| Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors App 20070072202 - Bates; Elizabeth Esther Mary ; et al. | 2007-03-29 |
| Mammalian dendritic cell chemokine reagents Grant 6,812,004 - Caux , et al. November 2, 2 | 2004-11-02 |
| Chemokine uses; compositions; methods App 20040042998 - Oldham, Elizabeth R. ; et al. | 2004-03-04 |
| Method for treating inflammatory conditions using an antibody to MIP-3.alpha. Grant 6,645,491 - Oldham , et al. November 11, 2 | 2003-11-11 |
| Methods for treating cancer App 20030138413 - Vicari, Alain ; et al. | 2003-07-24 |
| Chemokines as adjuvants of immune response App 20030077247 - Caux, Christophe ; et al. | 2003-04-24 |
| Isolated mammalian dendritic cell genes; related reagents App 20030032094 - Bates, Elizabeth Esther Mary ; et al. | 2003-02-13 |
| Methods for treating cancer App 20030008840 - Vicari, Alain P. ; et al. | 2003-01-09 |
| Chemokines as adjuvants of immune response App 20020034494 - Vicari, Alain P. ; et al. | 2002-03-21 |
| In vitro generation of human dendritic cells Grant 6,004,807 - Banchereau , et al. December 21, 1 | 1999-12-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 